DGFT extends the date for implementation of Track and Trace system for export of drug formulations till February 01, 2024

The DGFT issued Public Notice No. 26/2023 dated August 04, 2023 extends the date for implementation of the Track and Trace system for the export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on the Central Portal up to February 01, 2024 for both SSI and non SSI manufactured drugs.

In exercise of the powers conferred under Paragraph 2.04 of the Foreign Trade Policy 2023, as amended from time to time, the Director General of Foreign Trade hereby amends Para 2.90A of Handbook of Procedure-2015-20. as notified vide Public Notice No. 43/2015- 20 dated December 05, 2017 read with Public Notice No. 52/2015-20 dated January 05, 2016, Public Notice No. 05/2015-20 dated May 09, 2018, Public Notice No. 43/2015-2020 dated November 01, 2018, Public Notice No. 16/2015- 2020 dated July 04, 2019, Public Notice No. 66/2015- 2020 dated March 30, 2020, Public Notice No. 16/2015-2020 dated September 22, 2020, Public Notice No. 46/2015-20 dated March 30, 2021, Public Notice No. 01/2015-2020 dated January 04, 2022 and Public Notice No. 3/2023 dated April 03, 2023 on laying down the procedure for implementation of the Track and Trace system for export consignments of drug formulations.

In Para 2.76 (vi) and (vii) of Handbook of Procedure – 2023 (as amended erstwhile Para 2.90A of HBP 2015-2020), the date for implementation of Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal is extended up to February 01, 2024 for both SSI and non SSI manufactured drugs.

Effect of this Public Notice:

The date for implementation of Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal has been extended up to February 01, 2024 for both SSI and non SSI manufactured drugs.

The Public Notice can be accessed at:Β https://a2z-bucket.s3.ap-south-1.amazonaws.com/wp-content/uploads/2023/08/DGFT-P.N.-No.-26-2023-dated-04.08.2023-English.pdf

___________________________________________________________________________________

πŸ“’ FREE Webinar on β€œBlockchain and Virtual digital asset with overall taxation implications including GST” by CA Riddhi Jain & Adv (CA) Bimal Jain

πŸ”– TODAY is the LAST Day !! Register Now !!

πŸ”– A2Z Academy is Organizing a FREE Webinar On:

πŸ“’“Blockchain and Virtual digital asset with overall taxation implications including GST”

πŸ—“οΈ Date: August 04, 2023, Friday

⏰ Time: 8:00 PM to 9:00 PM (IST)

🎀 Speakers:

πŸ‘¨πŸ»β€πŸ« CA Riddhi Jain
Expert in Crypto Currency

πŸ‘¨πŸ»β€πŸ« CA (Adv) Bimal Jain
Chairman of Indirect & GST Committee of PHD Chamber of Commerce

Registration Link πŸ”—:Β 

https://zoom.us/webinar/register/WN_Kbvufgm6TyW-avGx6_3mfw

Coverage:

  • πŸ“ What is Block chain technology and Virtual digital assets?
  • πŸ“ What is the current legal status of virtual digital assets in India?
  • πŸ“ What is Income Tax implication on virtual digital assets in India?
  • πŸ“ How does the taxation of virtual digital assets differ from that of traditional financial assets?
  • πŸ“ How are virtual digital assets classified for taxation purposes under GST?
  • πŸ“ What is the GST rate applicable to the sale of virtual digital assets?
  • πŸ“ Are there any exemptions or special provisions for virtual digital assets under the GST?
  • πŸ“ How do crypto exchanges and other intermediaries comply with GST regulations?
  • πŸ“ Q&A and open discussion

Limited seats available

Follow us on our social media for more updates:

πŸ”Ή FacebookπŸ”Ή TwitterπŸ”Ή LinkedInπŸ”Ή InstagramπŸ”Ή YouTube

Scroll to Top